Editas Medicine Inc (EDIT)
2.425
+0.06
(+2.32%)
USD |
NASDAQ |
Nov 22, 10:10
Editas Medicine Profit Margin (Quarterly): -101.9K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -101.9K% |
| June 30, 2024 | -13.18K% |
| March 31, 2024 | -5.46K% |
| December 31, 2023 | -31.43% |
| September 30, 2023 | -843.7% |
| June 30, 2023 | -1.40K% |
| March 31, 2023 | -497.8% |
| December 31, 2022 | -929.3% |
| September 30, 2022 | -132.7K% |
| June 30, 2022 | -840.2% |
| March 31, 2022 | -746.0% |
| December 31, 2021 | -332.3% |
| September 30, 2021 | -630.7% |
| June 30, 2021 | -14.58K% |
| March 31, 2021 | -872.9% |
| December 31, 2020 | -547.3% |
| September 30, 2020 | 12.44% |
| June 30, 2020 | -219.3% |
| March 31, 2020 | -659.2% |
| Date | Value |
|---|---|
| December 31, 2019 | -307.5% |
| September 30, 2019 | -856.1% |
| June 30, 2019 | -1.45K% |
| March 31, 2019 | -1.41K% |
| December 31, 2018 | -409.5% |
| September 30, 2018 | -105.0% |
| June 30, 2018 | -525.3% |
| March 31, 2018 | -787.9% |
| December 31, 2017 | -986.9% |
| September 30, 2017 | -423.4% |
| June 30, 2017 | -853.7% |
| March 31, 2017 | -4.56K% |
| December 31, 2016 | -4.38K% |
| September 30, 2016 | -2.19K% |
| June 30, 2016 | -562.0% |
| March 31, 2016 | -2.20K% |
| December 31, 2015 | -1.60K% |
| September 30, 2015 | -1.11K% |
| June 30, 2015 | -28.49K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-132.7K%
Minimum
Sep 2022
12.44%
Maximum
Sep 2020
-13.83K%
Average
-793.1%
Median
Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | -105.0% |
| EyePoint Pharmaceuticals Inc | -279.0% |
| Cassava Sciences Inc | -- |
| Adverum Biotechnologies Inc | -2.71K% |
| Regenxbio Inc | -246.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -74.59% |
| Return on Assets | -48.82% |
| Return on Invested Capital | -74.59% |
| Operating Margin (Quarterly) | -107.6K% |
| Return on Net Operating Assets | -422.2% |